| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/23/2004 | WO2004080439A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | WO2004080436A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | WO2004080430A2 Methods of improving skin quality |
| 09/23/2004 | WO2004080429A2 Use of thiol-based compositions in ameliorating mucosal injury |
| 09/23/2004 | WO2004080423A2 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 09/23/2004 | WO2004080422A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 09/23/2004 | WO2004080417A2 Methods and compositions for blocking the calcium cascade |
| 09/23/2004 | WO2004080415A2 Gel composition and method for treatment of vaginal infections |
| 09/23/2004 | WO2004080414A2 Composition and method for treating inflammations by reducing c-reactive protein |
| 09/23/2004 | WO2004080413A2 Uses and formulations for transdermal or transmucosal application of active agents |
| 09/23/2004 | WO2004080411A2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004080410A2 Furanose-type bicyclic carbohydrates with biological activity |
| 09/23/2004 | WO2004080409A2 Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus |
| 09/23/2004 | WO2004080408A2 Method of treating cancer with azaspirane compositions |
| 09/23/2004 | WO2004080407A2 New serotonin modulating compounds and uses therefor |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080396A2 Liposomal curcumin for treatment of cancer |
| 09/23/2004 | WO2004080393A2 Selective cytokine inhibitory drugs for treating disorders of the central nervous system |
| 09/23/2004 | WO2004080391A2 Novel antibacterial agents |
| 09/23/2004 | WO2004080390A2 Antiprotozoal imidazopyridine compounds |
| 09/23/2004 | WO2004080383A2 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/23/2004 | WO2004080382A2 Novel compositions containing fentanyl |
| 09/23/2004 | WO2004080379A2 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect |
| 09/23/2004 | WO2004080371A2 Injectable isotonic solution of gatifloxacin pre-diluted in glucose. |
| 09/23/2004 | WO2004080343A2 Compositions and methods for use of alginate dural sealants |
| 09/23/2004 | WO2004080285A2 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity |
| 09/23/2004 | WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 09/23/2004 | WO2004080210A1 Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea |
| 09/23/2004 | WO2004080209A1 Serum remnant-like lipoprotein concentration regulator |
| 09/23/2004 | WO2004080206A1 Method and composition for preventing or reducing diarrhea |
| 09/23/2004 | WO2004080176A2 Microbicidal compositions including an ionene polymer and 2,4,4’-trichloro-2’-hydroxydiphenyl ether, and methods of using the same |
| 09/23/2004 | WO2004073682A3 Use of pvp-iodine liposomes for treatment of herpes |
| 09/23/2004 | WO2004069156A3 Inactivated probiotic bacteria and methods of use thereof |
| 09/23/2004 | WO2004069150A3 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 09/23/2004 | WO2004069029A3 Prevention of surgical adhesions using selective cox-2 inhibitors |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004067022A3 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 09/23/2004 | WO2004064845A8 Compositions and methods for combination antiviral therapy |
| 09/23/2004 | WO2004064723A3 Inhibitors and methods of use thereof |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004064708A3 Solution for nostril wash |
| 09/23/2004 | WO2004060348A3 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 09/23/2004 | WO2004060320A8 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus |
| 09/23/2004 | WO2004058353A3 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 09/23/2004 | WO2004058269A9 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 09/23/2004 | WO2004056320A3 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004052350A3 Method of treating movement disorders using barbituric acid derivatives |
| 09/23/2004 | WO2004052296A3 Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv |
| 09/23/2004 | WO2004047802A3 Liposomal formulations |
| 09/23/2004 | WO2004047752A3 Pharmaceutical formulations of celcoxib |
| 09/23/2004 | WO2004043913A3 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004041217A3 Synthetic lactone formulations and method of use |
| 09/23/2004 | WO2004041199A3 N-acetyl-d-glucosamine (nag) supplemented food products and beverages |
| 09/23/2004 | WO2004041155A3 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 09/23/2004 | WO2004039317A3 Analogs and prodrugs of buprenorphine |
| 09/23/2004 | WO2004038006A3 Purine nucleosides |
| 09/23/2004 | WO2004032858A3 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 09/23/2004 | WO2004030684A3 Kavalactone product |
| 09/23/2004 | WO2004030637A3 Treatment of obesity and other disorders associated with excessive food intake |
| 09/23/2004 | WO2004029137A3 Cross-linked polymer matrices, and methods of making and using same |
| 09/23/2004 | WO2004028444A3 Parathyroid hormone antagonists and uses thereof |
| 09/23/2004 | WO2004026930A3 The method for reducing inflammation using sti-571 or its salt |
| 09/23/2004 | WO2004021989A3 Imidazolopyridines and methods of making and using the same |
| 09/23/2004 | WO2004019921A3 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 09/23/2004 | WO2004017924A3 Methods of treating involuntary facial spasms and facial wrinkles |
| 09/23/2004 | WO2004013300A3 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003086295A3 Process for preparing tannate liquid and semi-solid dosage forms |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 09/23/2004 | WO2003072552A8 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/23/2004 | WO2003047341A3 Anti-microbial systems and methods |
| 09/23/2004 | WO2003037312A3 Ribavirin syrup formulations |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | US20040186587 Devices and methods for treating tissue |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186293 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186284 Methods for isolating crystalline form I of 5-azacytidine |
| 09/23/2004 | US20040186283 Synthesis of 5-azacytidine |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186186 Crystalline 4-cyclopentyl resorcinol monohydrate and its form I polymorph; lightening skin |
| 09/23/2004 | US20040186185 Method for treatment and chemoprevention of prostate cancer |
| 09/23/2004 | US20040186184 Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 09/23/2004 | US20040186183 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 09/23/2004 | US20040186182 Creating local analgesic effect without burning sensation; coadministering with sodium channel blocker to discrete painful site |
| 09/23/2004 | US20040186181 Method and composition for decreasing ghrelin levels |
| 09/23/2004 | US20040186180 Non-steroidal anti-inflammatory drug dosing regimen |
| 09/23/2004 | US20040186179 Pharmaceutical composition |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186177 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia |